Lisa McBryar
Nurse Practitioner · Atlanta, GANPI 1205954021
Payments from drug & device makers
Across 512 payments — averaging $17.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- Johnson & Johnson$1K
- Alkermes, Inc.$1K
- AbbVie$916
- Otsuka America Pharmaceutical, Inc.$615
- Lundbeck LLC$474
- plus $3K from 16 others
What the payments were for
- Food & beverage$8,94999%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 87 | $1,673 |
| Johnson & Johnson | 54 | $1,253 |
| Alkermes, Inc. | 57 | $1,085 |
| AbbVie | 84 | $916 |
| Otsuka America Pharmaceutical, Inc. | 32 | $615 |
| Lundbeck LLC | 23 | $474 |
| Corium, LLC | 27 | $430 |
| Teva Pharmaceuticals USA, Inc. | 21 | $330 |
| Noven Therapeutics, LLC | 18 | $330 |
| Tris Pharma Inc | 17 | $278 |
| Ironshore Pharmaceuticals Inc. | 15 | $260 |
| Supernus Pharmaceuticals, Inc. | 15 | $246 |
| Axsome Therapeutics, Inc. | 9 | $236 |
| Vanda Pharmaceuticals Inc. | 12 | $221 |
| Neurocrine Biosciences, Inc. | 9 | $190 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $160 |
| Sunovion Pharmaceuticals Inc. | 12 | $116 |
| Neos Therapeutics, LP | 4 | $56 |
| Bausch Health US, LLC | 2 | $40 |
| Acadia Pharmaceuticals Inc | 2 | $39 |
| Collegium Pharmaceutical, Inc. | 2 | $34 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
How this compares
$8,996 in reported general payments places this provider in the 95th percentile of 3,328 nurse practitioner providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 30 | $7,936 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 18 | $2,043 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 67 | $677 |
| Quetiapine Fumarate | 47 | $637 |
| Duloxetine Hcl | 14 | $501 |
| Hydroxyzine Hcl | 16 | $459 |
| Trazodone Hcl | 68 | $391 |
| Divalproex Sodium ErDivalproex Sodium | 18 | $299 |
| Lamotrigine | 14 | $220 |
| Amitriptyline Hcl | 11 | $215 |
| Buspirone Hcl | 29 | $200 |
| Fluoxetine Hcl | 43 | $180 |
| Aripiprazole | 12 | $134 |
| Sertraline Hcl | 17 | $123 |
| Gabapentin | 14 | $120 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Atlanta
- Janice McAlisterAtlanta$241K
- Laura ElledgeAtlanta$177K
- Casey MillerAtlanta$41K
- Kathryn InanAtlanta$17K
- Colby DoepelAtlanta$16K
- Mark HebertAtlanta$15K
- Ashley BlackmonAtlanta$13K
- Alexia CovingtonAtlanta$13K
- Marissa TorresAtlanta$12K
- Hayley TurnerAtlanta$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.